TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33901508

Group type: EXPERIMENTAL
Intervention: High-tensile strength tape with Krackow stitch
Number of subjects: 84

Group type: COMPARATOR
Intervention: High-tensile strength suture with Krackow stitch
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: High-tensile strength tape with whip stitch
Number of subjects: 84

Group type: COMPARATOR
Intervention: High-tensile strength suture with whip stitch
Number of subjects: 84
Study: 35177084

Group type: EXPERIMENTAL
Intervention: EQ-5D-Y-5L
Number of subjects: 83

Group type: COMPARATOR
Intervention: EQ-5D-Y-3L
Number of subjects: 83
Study: 34239941

Group type: EXPERIMENTAL
Intervention: Sleeplessness
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sleep duration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chronotype, getting up in the morning, nap during the day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sleeplessness and sleep duration (in multivariate MR analysis)
Number of subjects: 0
Study: 35159306

Group type: EXPERIMENTAL
Intervention: Energy Drink (ED)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 32851411

Group type: EXPERIMENTAL
Intervention: Ad26.RSV.preF plus Fluarix
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo plus Fluarix
Number of subjects: 180
Study: 35318529

Group type: EXPERIMENTAL
Intervention: Recovery Tracker (web-based patient-reported outcomes questionnaire)
Number of subjects: 23
Study: 32658425

Group type: COMPARATOR
Intervention: Elecsys hGH assay
Number of subjects: 0

Group type: COMPARATOR
Intervention: Elecsys IGF-1 assay
Number of subjects: 0
Study: 36496154

Group type: EXPERIMENTAL
Intervention: Internet-based self-management program (Pain EASE)
Number of subjects: 2529

Group type: EXPERIMENTAL
Intervention: Tailored physical therapy program (Enhanced PT)
Number of subjects: 2529

Group type: COMPARATOR
Intervention: Continued care with active monitoring (CCAM)
Number of subjects: 2529

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy for chronic pain (if re-randomized)
Number of subjects: 2529

Group type: EXPERIMENTAL
Intervention: Spinal manipulation therapy (if re-randomized)
Number of subjects: 2529

Group type: EXPERIMENTAL
Intervention: Yoga (if re-randomized)
Number of subjects: 2529
Study: 33558351

Group type: EXPERIMENTAL
Intervention: SISU software agent-based intervention, delivered over 3 consecutive days, based on therapeutic writing and acceptance and commitment therapy principles.
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: SISU software agent-based intervention
Number of subjects: 120

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 120
Study: 33008464

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (200,000 IU)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no vitamin A supplementation)
Number of subjects: 30
Study: 34235612

Group type: EXPERIMENTAL
Intervention: Esketamine nasal spray + oral antidepressant (AD)
Number of subjects: 1142

Group type: COMPARATOR
Intervention: Placebo nasal spray + oral antidepressant (AD)
Number of subjects: 1142

Group type: EXPERIMENTAL
Intervention: Esketamine nasal spray
Number of subjects: 1142

Group type: COMPARATOR
Intervention: Placebo nasal spray
Number of subjects: 1142
Study: 32121286

Group type: EXPERIMENTAL
Intervention: Maternal functioning (Barkin Index of Maternal Functioning - BIMF)
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: Mental health (Mental Health Inventory - MHI)
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: Maternal functioning and mental health relationship
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: Increased maternal functioning
Number of subjects: 530
Study: 36193847

Group type: EXPERIMENTAL
Intervention: Finerenone
Number of subjects: 13026
Study: 33811556

Group type: EXPERIMENTAL
Intervention: continuous AG (cAG)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: intermittent AG (iAG)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (CTRL)
Number of subjects: 24
Study: 32248089

Group type: EXPERIMENTAL
Intervention: BCI-SRG
Number of subjects: 11

Group type: COMPARATOR
Intervention: SRG
Number of subjects: 11
Study: 35734648

Group type: EXPERIMENTAL
Intervention: Pre-operative antibiotics (intravenous cefazolin 2-g)
Number of subjects: 100

Group type: COMPARATOR
Intervention: No pre-operative antibiotics
Number of subjects: 100
Study: 33045448

Group type: EXPERIMENTAL
Intervention: Transvaginal ovarian needle puncture prior to induction with aromatase inhibitors and gonadotropins
Number of subjects: 27

Group type: COMPARATOR
Intervention: Induction using aromatase inhibitors (Letrozol 2.5 mg twice daily for 5 days) and FSH (75 IU daily from cycle day 3)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Transvaginal ovarian needle puncture
Number of subjects: 27
Study: 33736523

Group type: COMPARATOR
Intervention: Statin prescription in HIV-negative patients
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Statin prescription in HIV-positive patients
Number of subjects: 150

Group type: COMPARATOR
Intervention: Aspirin prescription in HIV-negative patients
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Aspirin prescription in HIV-positive patients
Number of subjects: 150

Group type: COMPARATOR
Intervention: Smoking cessation counseling in HIV-negative patients
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Smoking cessation counseling in HIV-positive patients
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Current smokers in HIV-positive patients
Number of subjects: 150

Group type: COMPARATOR
Intervention: Current smokers in HIV-negative patients
Number of subjects: 150
Study: 34209080

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT) - supervised exercise twice a week for 12 weeks
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (CG) - no intervention
Number of subjects: 37
Study: 32686119

Group type: EXPERIMENTAL
Intervention: Hand‐Arm Bimanual Intensive Therapy (HABIT) (90 hours)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Customary care (4.5 hours)
Number of subjects: 41
Study: 34235875

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg once daily
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study: 32048945

Group type: EXPERIMENTAL
Intervention: Coaching model of communication skills for oncologists to facilitate GoC discussions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall productivity across four sites
Number of subjects: 0
Study: 36180155

Group type: EXPERIMENTAL
Intervention: Self-stretching with mindful breathing (MB)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Self-stretching without mindful breathing (Control)
Number of subjects: 30
Study: 34548100

Group type: EXPERIMENTAL
Intervention: Digital health peri-operative cognitive-behavioral intervention (SurgeryPalTM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 36498075

Group type: EXPERIMENTAL
Intervention: Low-load resistance exercise with blood flow restriction (LLRE-BFR)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Low-load resistance exercise (LLRE)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Moderate-load resistance exercise (MLRE)
Number of subjects: 20
Study: 32940695

Group type: EXPERIMENTAL
Intervention: Moderate caloric restriction (CR), 11.9% on average
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Moderate caloric restriction (CR)
Number of subjects: 218
Study: 34908536

Group type: EXPERIMENTAL
Intervention: Sodium valproate (20 mg/kg)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Lithium carbonate (up to a serum level of 0.8‐1.5 mEq/L)
Number of subjects: 50
Study: 32381151

Group type: EXPERIMENTAL
Intervention: VC injection pre-transit (5 g sodium ascorbate/steer)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Saline injection pre-transit and VC injection post-transit
Number of subjects: 90

Group type: COMPARATOR
Intervention: Saline injection pre- and post-transit (CON)
Number of subjects: 90
Study: 34510619

Group type: EXPERIMENTAL
Intervention: Disclosure of data limitations (technical)
Number of subjects: 1531

Group type: EXPERIMENTAL
Intervention: Disclosure of data limitations (nontechnical)
Number of subjects: 1531

Group type: EXPERIMENTAL
Intervention: Disclosure of clinical uncertainty (present)
Number of subjects: 1531

Group type: EXPERIMENTAL
Intervention: Disclosure of clinical uncertainty (absent)
Number of subjects: 1531

Group type: COMPARATOR
Intervention: Control (no disclosure)
Number of subjects: 1531
Study: 32016585

Group type: EXPERIMENTAL
Intervention: Adjuvant cisternostomy (AC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Decompressive craniectomy (DC)
Number of subjects: 40
Study: 36460492

Group type: EXPERIMENTAL
Intervention: Simulated surgical warm-up procedure prior to surgery
Number of subjects: 147

Group type: COMPARATOR
Intervention: Unprimed operative cases
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Priming
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Self-efficacy scores measured following priming
Number of subjects: 147
Study: 35174636

Group type: EXPERIMENTAL
Intervention: Nurse-led social media intervention
Number of subjects: 89
Study: 34085796

Group type: EXPERIMENTAL
Intervention: Sentinel lymph node (SLN) mapping
Number of subjects: 780

Group type: COMPARATOR
Intervention: Pelvic lymphadenectomy
Number of subjects: 780
Study: 32791379

Group type: EXPERIMENTAL
Intervention: Reliable syntax condition
Number of subjects: 2

Group type: COMPARATOR
Intervention: Reliable semantics condition
Number of subjects: 2
Study: 35115023

Group type: EXPERIMENTAL
Intervention: Breaking the Man Code workshops
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 0
Study: 34437978

Group type: EXPERIMENTAL
Intervention: Mast-cell inhibitors
Number of subjects: 326

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 326
Study: 36123051

Group type: EXPERIMENTAL
Intervention: Inforatio technique with usual care
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 100
Study: 32853271

Group type: EXPERIMENTAL
Intervention: Intervention arm (SLATE II algorithm)
Number of subjects: 593

Group type: COMPARATOR
Intervention: Standard arm (usual care)
Number of subjects: 593
Study: 34509670

Group type: EXPERIMENTAL
Intervention: Group B (short stay, discharge the day after the intervention)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Group A (conventional hospital stay of 2 to 3 days)
Number of subjects: 42
Study: 33318126

Group type: EXPERIMENTAL
Intervention: Dapagliflozin (10 mg)
Number of subjects: 16
Study: 32193889

Group type: EXPERIMENTAL
Intervention: Clinical-CT index
Number of subjects: 2218

Group type: COMPARATOR
Intervention: CTL-S
Number of subjects: 2218

Group type: COMPARATOR
Intervention: Clinical indices
Number of subjects: 2218
Study: 33524549

Group type: EXPERIMENTAL
Intervention: EMLA (eutectic mixture of lidocaine 2.5% and prilocaine 2.5%)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Capsaicin
Number of subjects: 24

Group type: COMPARATOR
Intervention: EMLA alone
Number of subjects: 24
Study: 32142084

Group type: EXPERIMENTAL
Intervention: 1 gram of pure eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), or docosahexaenoic acid (DHA) daily for 6 days
Number of subjects: 10

Group type: COMPARATOR
Intervention: Olive oil
Number of subjects: 10
Study: 36414937

Group type: EXPERIMENTAL
Intervention: Supplementary suckling technique with high or low protein milk-based formula supplement
Number of subjects: 108
Study: 33229425

Group type: EXPERIMENTAL
Intervention: Pretomanid with rifampin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pretomanid with rifabutin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pretomanid alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pretomanid with food and rifampin
Number of subjects: 0
Study: 32878631

Group type: EXPERIMENTAL
Intervention: Higher levels of unconjugated bilirubin (UCB) in men; per 1-SD increment of log-UCB
Number of subjects: 1386

Group type: EXPERIMENTAL
Intervention: Higher levels of unconjugated bilirubin (UCB) in women; per 1-SD increment of log-UCB
Number of subjects: 1386

Group type: EXPERIMENTAL
Intervention: Genetically predicted higher levels of total bilirubin in men; per 1-SD increment of total bilirubin
Number of subjects: 1386

Group type: EXPERIMENTAL
Intervention: Genetically predicted higher levels of total bilirubin in women; per 1-SD increment of total bilirubin
Number of subjects: 1386
Study: 35617820

Group type: EXPERIMENTAL
Intervention: Manufacturer group (IPS e.max ZirCAD MT A2)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Brush group (unshaded ceramic disc pigmented at the pre‐sintered stage)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Immersion group (unshaded ceramic disc pigmented through immersion)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (non‐pigmented specimens)
Number of subjects: 15
Study: 34334774

Group type: EXPERIMENTAL
Intervention: Short intervals (SIs)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Long intervals (LIs)
Number of subjects: 18
Study: 32652012

Group type: EXPERIMENTAL
Intervention: ACGG + ATONU
Number of subjects: 829

Group type: EXPERIMENTAL
Intervention: ACGG
Number of subjects: 829
Study: 36463226

Group type: EXPERIMENTAL
Intervention: CC-486 (300 mg daily on days 1-21 of a 28-day cycle)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Observation (OBS)
Number of subjects: 49
Study: 32364091

Group type: EXPERIMENTAL
Intervention: Casein protein (CP) 25 g
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 14
Study: 33159632

Group type: EXPERIMENTAL
Intervention: Pediatric Autism Spectrum Therapy Observation System (PASTOS)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Cognitive behavioral therapy (manual-based)
Number of subjects: 22
Study: 32857955

Group type: EXPERIMENTAL
Intervention: Stay-at-home orders (lockdowns)
Number of subjects: 2424
Study: 35798178

Group type: EXPERIMENTAL
Intervention: Selective Serotonin Reuptake Inhibitors (SSRIs)
Number of subjects: 101
Study: 33439781

Group type: EXPERIMENTAL
Intervention: Lower tidal volume (Vt) ventilation strategies
Number of subjects: 1096
Study: 33317593

Group type: EXPERIMENTAL
Intervention: REP+EF add IF
Number of subjects: 0

Group type: COMPARATOR
Intervention: REP+EF/IF
Number of subjects: 0

Group type: COMPARATOR
Intervention: REP+EF only
Number of subjects: 0
Study: 35869933

Group type: EXPERIMENTAL
Intervention: low carbohydrate/high fat with high energy availability (LCHF)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: low energy availability (LEA)
Number of subjects: 28

Group type: COMPARATOR
Intervention: high carbohydrate/high energy availability diet (CON)
Number of subjects: 28
Study: 32951512

Group type: EXPERIMENTAL
Intervention: Psychosocial stress
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 65
Study: 35920954

Group type: EXPERIMENTAL
Intervention: Guided by a protocol
Number of subjects: 193

Group type: COMPARATOR
Intervention: Not guided by a protocol
Number of subjects: 193
Study: 32187744

Group type: EXPERIMENTAL
Intervention: Language-motor intervention
Number of subjects: 108

Group type: COMPARATOR
Intervention: Motor control
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 108
Study: 36502287

Group type: EXPERIMENTAL
Intervention: Bright Bodies intervention (high-intensity, family-based pediatric weight management)
Number of subjects: 396
Study: 34585263

Group type: EXPERIMENTAL
Intervention: TXA 10mg/kg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (normal saline in equal volumes)
Number of subjects: 80
Study: 32513936

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (OT), 40 IU, administered as a single acute dose over 18–26 min post dosing.
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo, administered as a control treatment.
Number of subjects: 47
Study: 35578302

Group type: EXPERIMENTAL
Intervention: Traditional Acupuncture (TA)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Laser Acupuncture (LA)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Sham (placebo intervention)
Number of subjects: 84
Study: 34887656

Group type: EXPERIMENTAL
Intervention: RESP-FIT + Smartphone Airway Management System (SAMS) program, a 6-week, self-management, technology-enhanced respiratory muscle strength training (RMST) intervention
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 30
Study: 33989967

Group type: EXPERIMENTAL
Intervention: Individualized group (n = 76)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Conventional group (n = 72)
Number of subjects: 148
Study: 35253516

Group type: EXPERIMENTAL
Intervention: 50 µg LSD
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 75 µg LSD
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 100 µg LSD
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 50 µg followed by 75 µg LSD (1 week apart)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo followed by 75 µg LSD (1 week apart)
Number of subjects: 32
Study: 33795787

Group type: EXPERIMENTAL
Intervention: Opioid-sparing protocol
Number of subjects: 56

Group type: COMPARATOR
Intervention: Opioid-based protocol
Number of subjects: 56
Study: 32307626

Group type: EXPERIMENTAL
Intervention: Poor oral health knowledge, high dental anxiety, brushing teeth less than once a day, and regular consumption of chocolates or biscuits.
Number of subjects: 1207

Group type: EXPERIMENTAL
Intervention: Gingival bleeding
Number of subjects: 1207

Group type: EXPERIMENTAL
Intervention: Father's education level (father went to college)
Number of subjects: 1207

Group type: EXPERIMENTAL
Intervention: Higher family income
Number of subjects: 1207
Study: 35773666

Group type: EXPERIMENTAL
Intervention: Rigidfix femoral cross‐pin and Intrafix tibial extension sheath with tapered expansion screw
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Rigidfix femoral and BioScrew interference screw tibial fixation
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: BioScrew femoral and Intrafix tibial fixation
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: BioScrew fixation into both tunnels
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 120
Study: 34129666

Group type: EXPERIMENTAL
Intervention: Tooth-borne rapid maxillary expansion (TB RME)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Bone-borne rapid maxillary expansion (BB RME)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Comparison between TB RME and BB RME
Number of subjects: 40
Study: 32678783

Group type: EXPERIMENTAL
Intervention: Tactile cues delivered through a wearable device
Number of subjects: 39

Group type: COMPARATOR
Intervention: Visual signals
Number of subjects: 39

Group type: COMPARATOR
Intervention: Visuo-tactile cues
Number of subjects: 39
Study: 36384651

Group type: EXPERIMENTAL
Intervention: Whole Food Plant-Based (WFPB)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Plant-Based Meat Alternatives (PBMA)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Omnivorous diet (Animal)
Number of subjects: 22
Study: 32066404

Group type: EXPERIMENTAL
Intervention: Goldilocks work principle intervention, involving participatory workshops and implementation of 'Goldilocks-games' for 10 weeks.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual-practice wait-list control group.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Goldilocks work principle intervention.
Number of subjects: 0
Study: 34454653

Group type: EXPERIMENTAL
Intervention: Bevacizumab plus erlotinib
Number of subjects: 228

Group type: COMPARATOR
Intervention: Erlotinib alone
Number of subjects: 228
Study: 34034822

Group type: EXPERIMENTAL
Intervention: WeChat-based educational intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 36334250

Group type: EXPERIMENTAL
Intervention: Quadratus lumborum block (QLB)
Number of subjects: 75

Group type: COMPARATOR
Intervention: General anesthesia (GA)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Transverse abdominis plane block (TAPB)
Number of subjects: 75
Study: 33649451

Group type: COMPARATOR
Intervention: Bladder antimuscarinics (oxybutynin, propiverine, tolterodine, solifenacin, trospium, darifenacin, and fesoterodine) used for at least 1 year before the index date.
Number of subjects: 2

Group type: COMPARATOR
Intervention: No bladder antimuscarinic treatment (control group).
Number of subjects: 2
Study: 33350739

Group type: EXPERIMENTAL
Intervention: Mobile application (app) for self-exercise program
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Mobile application (app) with real-time feedback
Number of subjects: 200

Group type: COMPARATOR
Intervention: Physical education data (booklets)
Number of subjects: 200
Study: 34112019

Group type: EXPERIMENTAL
Intervention: Standard semi-permeable dressing and clear tape with cyanoacrylate glue (SPD + CG)
Number of subjects: 350

Group type: COMPARATOR
Intervention: Standard semi-permeable dressing and clear tape (SPD)
Number of subjects: 350
Study: 32909511

Group type: EXPERIMENTAL
Intervention: Trimetazidine (TMZ), 20 mg thrice daily orally 24 hours before and 72 hours after PCI
Number of subjects: 310

Group type: COMPARATOR
Intervention: Control group (hydration only)
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Trimetazidine (TMZ)
Number of subjects: 310
Study: 32960532

Group type: EXPERIMENTAL
Intervention: Mepivacaine
Number of subjects: 154

Group type: COMPARATOR
Intervention: Low-dose bupivacaine
Number of subjects: 154
Study: 36129693

Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 9673

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9673
Study: 32602273

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 35860451

Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 201

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 201
Study: 34321057

Group type: EXPERIMENTAL
Intervention: Telephonic befriending intervention
Number of subjects: 1440

Group type: COMPARATOR
Intervention: General enquiry phone call (control)
Number of subjects: 1440
Study: 32418538

Group type: EXPERIMENTAL
Intervention: Cartoon character condition (n = 1789)
Number of subjects: 3755

Group type: COMPARATOR
Intervention: Control condition (n = 1966)
Number of subjects: 3755
Study: 35221673

Group type: EXPERIMENTAL
Intervention: Tadalafil (5 mg) alone
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Amlodipine (10 mg) alone
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Tadalafil plus amlodipine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Combined administration of tadalafil and amlodipine
Number of subjects: 24